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Editorial on the Research Topic
Natural Killer Cells in Tissue Compartments
Most of our current knowledge about human natural killer (NK) cells comes from studies on
cells derived from peripheral blood, also known as “conventional” NK cells (c-NK), but recently,
interest in the characterization of NK cells within tissues has increased, and besides recirculating
cells, different tissue resident NK cells (tr-NK), each possessing distinct phenotypic profiles, have
been described.
This Research Topic gathers themost recent information in the field to consolidate the emerging
pictures of NK cells in the different organs, and to explain how the homeostasis of these unique NK
cell subsets is normally maintained, or altered in pathologic conditions. The topic has successfully
collected articles focused on a number of tissues, covering most of the compartments where NK
cells are currently under study.
Two articles focus on the bone marrow (BM), where hematopoietic stem cells (HSC), or
common lymphoid precursors (CLP) can generate mature NK cells or move to secondary lymphoid
organs or peripheral tissues to differentiate under the influence of specific local microenvironments.
By reviewing the recent literature and also their own data Bonanni et al. and Bozzano et al. depict
a quite complex scenario in which BM, besides supporting NK cell and other innate lymphoid
cell (ILC) development, can also orchestrate the NK cell mediated responses to infections. For
example, a peculiar Lin−CD34+DNAM1hiCXCR4+ CLP subset with the potential of generating
fully functional NK cells and reaching peripheral inflamed tissues can exit the BM upon prolonged
systemic inflammation. Additionally, mature NK cells can also leave the BM, reach infected
peripheral tissues and recirculate from the peripheral blood to the BM. Here, mature NK cells can
undergo homeostatic or infection-induced proliferation contributing to their reservoir and also to
the generation of “memory-like” long-lived NK cells. In T.Gondii-infected mice, BM NK cells can
also induce, via IFNγ, regulatory monocytes to control exaggerated, tissue damaging, inflammatory
responses. These NK cells could resemble the human BM-resident NK cell population characterized
by low cytotoxicity and high IFNγ production.
The exit from BM of precursors or relatively immature NK cells emphasizes the question on the
origins and homeostasis of specialized NK cell populations in specific tissues. This question applies,
for example, to the uterus. UterineNK cells (u-NK) represent a heterogeneous population endowed
with peculiar functions, spanning from the support of embryo development, to the maternal-fetal
tolerance, to the control of infection. Strikingly, this population undergoes important changes upon
the transition from the steady state to pregnancy, e.g., u-NK cell frequency dramatically increases
in the decidua after embryo implantation. How the dynamics of this population are regulated by
the local proliferation of tr-NK cells and/or migration and adaptation of c-NK cells remains an
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interesting and incompletely addressed question. Based on data
from murine virgin or pregnant uteri, Sojka et al. propose a two-
wave hypothesis for u-NK cell accumulation during pregnancy.
The first wave is due to the local proliferation of tr-NK cells
during decidualization, whereas the second, occurring during
the placentation, involves the recruitment of peripheral c-NK
cells. Importantly, these c-NK cells participate in spiral arteriole
remodeling by acting on endothelial and decidual stromal cells in
an IFNγ-dependent way.
In healthy pregnancy, the pool of human
decidual NKs includes poorly cytotoxic
TbetposEOMESposCD56brightCD16−KIR+ cells, expressing
tissue residency markers (CD69, CD49a, integrin b7, and CD9),
and even the inhibitory receptor, 2B4. However, these cells
become fully active during viral infections, demonstrating
their high plasticity. This issue is discussed by Jabrane-Ferrat,
who suggests that the increased NK cell cytotoxicity depends
on education via NKG2A- and/or KIR-mediated recognition
of HLA molecules on fetal trophoblast cells, and on NKp46
signaling and/or cytokine stimulation during viral infections.
A suppressed u-NK cell phenotype and function may
contribute to the progression of endometrial tumors. Degos
et al. show that u-NK cells are minimally present in the tumor
infiltrate, at least in part secondary to alterations in chemokines
(CXCL12, IP-10, and CCL27) and cytokines (IL-1β and IL-6)
that are present in the tumor microenvironment. Moreover,
tumor resident CD103+ u-NK cells are characterized by reduced
cytotoxicity and increased expression of inhibitory checkpoint
receptors, such as TIGIT, and TIM-3, as compared to recruited
CD103− c-NK cells.
Three Research Topic articles focus on human liver,
an organ in which NK cells represents almost 50% of all
intrahepatic lymphocytes. As described in detail by Mikulak
et al., human liver contains three NK cell populations showing
transcriptional and phenotypic differences: liver tr-NK cells,
memory-like NK cells and recirculating c-NK cells. Liver
tr-NK cells are enriched in CD56bright NK cells and are
characterized by a peculiar transcription factor profile that
includes Hobit, Tbet and increased Eomes expression. This
profile is in line with the known liver tr-NK cell phenotype
EomeshiTbetloTIGIT+CD69+CXCR6+CD49e−. Retention of
liver tr-NK cells is probably due to their expression of CXCR6,
CXCR3, and CCR5. Indeed, these receptors can interact with
CXCL16, CCL3, and CCL5 produced by cholangiocytes, liver
sinusoidal endothelial cells, Kupffer cells and hepatocytes, thus
favoring tr-NK cells homing to liver. According to the authors,
these liver tr-CD56bright NK cells also include an interesting
small subset expressing CD49a and CD94:NKG2C that could
be related to a clonal expansion in response to viral infections.
These so–called memory-like tr-NK cells, however, may be
different from the adaptive NK cells of the peripheral blood
that develop/expand in CMV+ or CMV-reactivating donors.
The situation is different for CD16+Siglec9+ NK cells found
in the liver that are Tbet+Eomes+ and likely represent c-NK
cells recirculating through the liver blood system without being
retained in the organ.
Harmon et al. have analyzed the soluble factors produced in
the liver microenvironment that can regulate the liver tr-NK cell
phenotype in humans. In particular they analyze the role of TGF-
β in suppression of Tbet and expression of Eomes in liver tr-NK
cells. Notably, blocking TGF-β signaling through pre-treatment
with a specific inhibitor reverses the phenotype of liver tr-NK
cells toward that of peripheral blood c-NK cells. Interestingly,
liver tr-NK cells share many phenotypic characteristics with u-
NK cells (CD56bright Eomeshi CD69+), probably as a result of
TFG-β in both the tissues.
The importance of the local microenvironment in shaping
the NK cell compartment has also been demonstrated in
non-alcoholic ratty liver diseases, namely in non-alcoholic
steatohepatitis (NASH). In this study, Stiglund et al. highlight
the phenotypic modification (i.e., an increased expression of
NKG2D) of liver tr-NK cells as well as considerable alterations
between liver and adipose tr-NK cells, as well as peripheral blood
c-NK cells, independent of disease status.
Poggi et al. provide an overview of NK cells in the context
of the gut lymphoid tissue. According to the authors’ view,
this scarce population, scattered within the lamina propria,
can nevertheless play important roles in different pathologies,
including inflammatory bowel diseases (IBD), and cancer.
Indeed, although it is still uncertain as to the composition of
this population in terms of c- or tr-NK cells, different studies
referenced in the article suggest peculiar regulatory features of
gut NK cells, which may influence TH1/TH17 or TH2 responses
in IBD. On the other hand, the authors describe the anti-tumor
function of gut NK cells in the context of certain subtypes of
colon cancer.
An involvement of NK cells in pathogenic processes is
highlighted in the review by Turner et al. on the kidney. NK
cells represent ∼25% of lymphocytes in healthy human kidney,
and contain an important fraction of CD56bright cells (37% of
total kidney-NK cells). The expression of CD69, predominant in
CD56bright cells, and parabiosis experiments inmice, indicate that
kidney harbors both tr- and c-NK cells. tr-NK cells are involved
in both acute kidney injury, being attracted, and activated by
damaged tubular epithelial cells, and in chronic kidney disease,
supporting the progression of interstitial fibrosis. c-NK cells
may be of pathogenic relevance during kidney graft rejection,
indeed they can induce ADCC against the allograft by the CD16-
mediated binding of donor-specific antibodies.
Two Research Topic articles focus on lung NK cells. By
reviewing different manuscripts in the field, Hervier et al.
describe the landscape of NK cells present in the lung.
The majority (up to 80%) of these cells displays a mature
CD56dimCD16+ phenotype and circulate between the organ and
peripheral blood. The remaining cells include the lung tr-NK cells
that are characterized by the CD16-CD49a+CD69+CD103+
surface phenotype. Also, in this case, the impact of the local
microenvironment likely plays a role in shaping the phenotypic
and functional features of lung tr-NK cells. Interestingly,
Scharenberg et al. describe marked NK cell hyperresponsiveness,
particularly in CD56brightCD16- NK cells, during Influenza A
virus infection, both in human lung and blood.
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Bonaccorsi et al. focus on a still poorly investigated issue:
the possible role of NK cells in the carotid atherosclerotic
plaques (CAP) formation. They show that NK cells are
present in the plaques, primarily in symptomatic patients, and
are enriched for CD56bright perforinlow/neg cells and express
markers of tissue residency (i.e., CD103, CD69, and CD49a).
Such plaque tr-NK cells (CAP-NK) might preferentially be
recruited via CCR7 (as high levels of CCL19 and CCL21
could be measured in the plaque) and then induced to up-
regulate markers of tissue residency under the influence of
local inflammation. According to the authors, CAP-NK cells
may participate in the disease process by favoring both the
progression of the atherosclerotic process within carotid plaques
and promoting plaque instability. Indeed, CAP-NK cells produce
the pro-inflammatory cytokine IFNγ, which can also induce
matrix metalloproteinases (MMPs) possibly affecting plaque
stability. On the other hand, MMPs may also contribute to the
abundant shedding of activating NK-receptor ligands found in
the plaques.
An additional tissue to be considered when studying NK cells
is that of the tumor. Although this issue could be the subject of
a dedicated Research Topic, we here present a few contributions
highlighting two specific components when considering any NK
cell-based immunotherapeutic strategy: NK cell checkpoints and
tumor infiltration by NK cells.
Pesce et al. analyze peritoneal carcinomatosis (PC) and
describe a compromised function of NK cells present in the
peritoneal fluid (PF) of high-grade, and even low-grade, PC
patients. PF NK cells of low-grade PC patients include a
large fraction of immature NKG2A+KIR-CD57-CD16dim cells
characterized by a strong downregulation of the main activating
NK cell receptors (such as NKp30, DNAM-1, and CD16).
By contrast, and perhaps interestingly, PF NK cells of high-
grade PC patients have a mature phenotype (KIR+ CD57+
NK cells) but show increased expression of the immune
checkpoint PD-1.
Parodi et al. analyze NK cells in setting of tissue hypoxia, a
condition frequently occurring within the tumor itself. Besides
presenting the hypoxia-induced transcriptome of NK cells, the
study also highlights how the decreased O2 tension can influence
the pattern of chemokine receptor expression, ultimately
favoring the migration of poorly cytotoxic CD56brightCD16dim
NK cells. Thus, local conditions, such as hypoxia, can
directly act on the expression of specific chemokine receptors
and affect migration of specific NK cell subsets, thereby
having a significant impact on tumor escape from effective
immune surveillance.
In this context, Ingegnere et al. have described a new (virus-
free) protocol for the production of NK cells transfected with
the CCR7 chemokine receptor. Interestingly, this transfection
method could be applied to other chemokine receptors to induce
NK cell migration to different tissues and tumor sites. This
approachmay be combined with the transfection of NK cells with
chimeric antigen receptors (CAR) that target tumor-associated
antigens (i.e., CAR-NK cells).
Although not initially considered in the original framework
of this issue on tissue NK cells, we decided to invite some
additional contributions focused on ILCs, due to the now
obvious relationship between NK cell differentiation and other
ILC subsets (namely group 1 ILCs), as well as their reciprocal
functional interactions. A Review article by Mariotti et al.
discusses the topical issue of the checkpoint receptors, their
expression on NK cells and other ILCs, and the known and
hypothesized implications in cancer, in defense against infectious
pathogens, and in pregnancy. Two research articles by Manson
et al. and Carvelli et al. focus on trauma and hemorrhagic or
septic shock, respectively, and on the related altered immune
responses which often result in adverse outcomes. In particular,
the changes within ILCs or with innate-like lymphocytes
are investigated and the possible consequences on immune
homeostasis are discussed.
Finally, a collection of articles on tissue NK cells and ILCs
could not be complete without consideration of their common
key receptors, the natural cytotoxicity receptors (NCRs). Two
reviews, by Barrow et al. and Parodi et al., focus on this issue,
providing a thorough and updated picture of these receptors in
both NK cells and ILCs. Interestingly, both the articles highlight
the polyfunctionality of these receptors, consistent with the well-
established multifaceted role of NK cells and ILCs in different
tissue compartments.
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